Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
Clin Imaging. 2021 Jan;69:311-317. doi: 10.1016/j.clinimag.2020.10.004. Epub 2020 Oct 6.
To evaluate the diagnostic performance for margin assessment of specimen radiography (SR) in breast conserving surgery (BCS) using radioactive I-seed localization (RSL).
The clinical, radiographic and histopathological data of women who underwent BCS after pre-operative RSL with intraoperative SR during nine consecutive years were analyzed. The histological margin and radiographic margin outcomes on SR were compared and results of intraoperative re-excisions were investigated.
A consecutive series of 448 women with invasive carcinoma (n = 211), ductal carcinoma in situ (DCIS) (n = 79) and a combination of DCIS and invasive carcinoma (n = 158) were included. The median minimal margins for the radiological masses and microcalcifications measured on SR were 14 mm and 11 mm, respectively. Based on a radiological cut-off SR margin value of 1 mm, the overall sensitivity, specificity, and positive and negative predictive values (PPV and NPV) were 21.0%, 95.0%, 26.0%, and 94.0%, respectively. The area under the receiver-operating curve was 0.73. Intraoperative re-excisions based on SR were performed in 31 (6.9%) patients; histopathological examination of the additional excised tissue revealed DCIS or invasive carcinoma in 6 (19.4%) patients. Hence, SR was beneficial for 6/448 patients (1.3%), and unnecessary intraoperative re-excisions were performed in 20/448 patients (4.5%). The number need to treat is 75; this implies that per 75-SR one resection with involved margins is prevented.
SR has a moderate diagnostic performance for margin involvement using RSL. A more accurate intraoperative margin assessment tool is warranted.
评估放射性 I 种子定位(RSL)引导下保乳手术(BCS)术中应用标本放射照相术(SR)评估切缘的诊断性能。
分析了 9 年内连续 448 例行术前 RSL 加术中 SR 行 BCS 的女性患者的临床、放射影像学和组织病理学资料。比较了 SR 上的组织学切缘和放射学切缘结果,并研究了术中再次切除的结果。
连续系列包括浸润性癌(n=211)、导管原位癌(DCIS)(n=79)和 DCIS 与浸润性癌混合(n=158)的 448 例女性患者。SR 上测量的放射学肿块和微钙化的最小切缘中位数分别为 14mm 和 11mm。基于 SR 上的放射学切缘值 1mm 的截断值,整体灵敏度、特异性、阳性预测值(PPV)和阴性预测值(NPV)分别为 21.0%、95.0%、26.0%和 94.0%。受试者工作特征曲线下面积为 0.73。根据 SR 进行了 31 例(6.9%)患者的术中再次切除;额外切除组织的组织病理学检查显示 6 例(19.4%)患者有 DCIS 或浸润性癌。因此,SR 对 6/448 例患者(1.3%)有益,对 20/448 例患者(4.5%)进行了不必要的术中再次切除。需要治疗的人数为 75;这意味着每 75 例 SR 中,有 1 例切除边缘受累。
SR 对 RSL 引导下保乳手术中切缘受累具有中等诊断性能。需要更准确的术中切缘评估工具。